SCHEMBL2805900

SCHEMBL2805900

CN(C)CC(C)(C)CNc1ncc2c(n1)-c1ccccc1C(c1ccccc1Cl)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.44
FGFR2 P21802 2/20 0.39
IGF1R P08069 2/20 0.39
CSF1R P07333 1/20 0.39
FGFR3 P22607 1/20 0.39
HTR2A P28223 4/20 0.35
HTR2C P28335 4/20 0.35
HTR2B P41595 4/20 0.35
HRH3 Q9Y5N1 4/20 0.35
MAPK14 Q16539 1/20 0.33
CDK2 P24941 2/20 0.33
MAPK9 P45984 2/20 0.33
PRKD3 O94806 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CSNK1D P48730 1/20 0.33
GSK3B P49841 1/20 0.33
PRKD2 Q9BZL6 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
KDR P35968 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13126227 0.89 FGFR1 (0.44) FGFR1FGFR2IGF1RCSF1RFGFR3
SCHEMBL2803025 0.89 FGFR1 (0.49) FGFR1FGFR2IGF1RCSF1RFGFR3
SCHEMBL2806766 0.83 FGFR1 (0.41) FGFR1FGFR2IGF1RCSF1RFGFR3
SCHEMBL2804022 0.80 FGFR1 (0.43) FGFR1FGFR2IGF1RCSF1RFGFR3
SCHEMBL2804043 0.80 FGFR1 (0.47) FGFR1FGFR2CSF1RFGFR3HRH3
SCHEMBL2802249 0.79 FGFR1 (0.42) FGFR1FGFR2IGF1RCSF1RFGFR3
SCHEMBL2803090 0.79 FGFR1 (0.54) FGFR1FGFR2IGF1RCSF1RFGFR3
SCHEMBL2804796 0.77 FGFR1 (0.49) FGFR1FGFR2CSF1RFGFR3PRKD3
SCHEMBL17057491 0.77 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3KDM4E
SCHEMBL2802449 0.77 FGFR1 (0.44) FGFR1FGFR2IGF1RCSF1RFGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885IGF1R 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.